Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The gross margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
GROSS MARGIN
0.00%
GROSS MARGIN AVG TTM
0.00%
GROSS MARGIN AVG 3Y
0.00%
GROSS MARGIN AVG 5Y
0.00%
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
41.38%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
NOMAD Power Solutions, Inc.
Market Cap
$52.72M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$53.24M
Gross Margin
-29.12%
TTM Avg
13.64%
3Y Avg
-48.92%
5Y Avg
-105.92%
Market Cap
$53.55M
Gross Margin
20.51%
TTM Avg
34.75%
3Y Avg
47.46%
5Y Avg
49.68%
Market Cap
$53.62M
Gross Margin
41.51%
TTM Avg
45.14%
3Y Avg
44.16%
5Y Avg
37.16%
Market Cap
$53.93M
Gross Margin
44.89%
TTM Avg
72.44%
3Y Avg
36.22%
5Y Avg
57.48%
Market Cap
$51.19M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| NOMAD Power Solutions, Inc. (NMAD) | $52.72M | 0.00% | 0.00% | 0.00% | 0.00% |
| ImageneBio Inc (IMA)vs › | $53.24M | -29.12% | 13.64% | -48.92% | -105.92% |
| Aldeyra The (ALDX)vs › | $53.29M | 0.00% | 0.00% | 0.00% | 0.00% |
| Zhengye Biotechnology Holding Limited (ZYBT)vs › | $53.55M | 20.51% | 34.75% | 47.46% | 49.68% |
| Spectral AI, Inc. (MDAI)vs › | $53.62M | 41.51% | 45.14% | 44.16% | 37.16% |
| Rani Therapeutics Holdings, Inc. (RANI)vs › | $53.93M | 44.89% | 72.44% | 36.22% | 57.48% |
| biote Corp. (BTMD)vs › | $51.61M | 71.46% | 70.99% | 69.42% | 67.35% |
| eXoZymes, Inc. (EXOZ)vs › | $51.51M | 0.00% | 0.00% | 0.00% | 0.00% |
| Tenax Therapeutics, Inc. (TENX)vs › | $51.19M | 0.00% | 0.00% | 0.00% | 0.00% |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $51.72M | N/A | 50.00% | 25.00% | 16.67% |
Gross Margin
0.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
